Chemo Pharma Laboratories

123.00
0.00
(0.00%)
Market Cap
18.50 Cr
EPS
-9.66
PE Ratio
53.95
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
154.00
52 Week Low
55.10
PB Ratio
1.40
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,710.00
#1 4,10,286.28
35.38
#1 49,887.20
12.06
#1 9,648
-18.99
46.80
6,791.00
1,80,279.71
81.41
8,184.00
0.89
1,600
23.05
64.39
1,517.60
1,22,563.64
23.31
26,520.70
14.17
4,155
30.28
59.81
1,364.10
1,13,828.06
19.93
28,905.40
12.36
5,578
21.14
83.47
3,263.00
1,10,434.75
56.27
10,785.70
11.59
1,656
10.91
51.39
2,408.00
99,348.91
49.40
10,615.60
19.57
1,942
-10.91
42.35
983.25
98,937.96
21.09
19,831.50
13.82
3,831
-0.19
74.24
2,042.50
93,248.49
28.22
20,141.50
#1 19.94
1,936
#1 112.49
54.77
1,165.80
67,709.85
#1 19.50
29,559.20
17.55
3,169
-0.50
47.18
31,420.00
66,765.31
47.51
6,097.20
10.80
1,201
27.83
61.77
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-101.57 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2016
TTM
Revenue
-1
0
Expenses
0
0
EBITDA
-1
0
Operating Profit %
0 %
0 %
Depreciation
0
0
Interest
0
0
Profit Before Tax
-1
0
Tax
0
0
Net Profit
-1
0
EPS in ₹
-9.66
0.00

Balance Sheet

Balance Sheet
2016
Total Assets
4
Fixed Assets
0
Current Assets
2
Capital Work in Progress
0
Investments
0
Other Assets
4
Total Liabilities
4
Current Liabilities
0
Non Current Liabilities
0
Total Equity
4
Reserve & Surplus
2
Share Capital
2

Cash Flow

Cash Flow
2016
Net Cash Flow
0
Investing Activities
2
Operating Activities
-2
Financing Activities
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.28 %
0.17 %
0.17 %
0.17 %
0.17 %
0.17 %
0.37 %
0.37 %
0.37 %
0.17 %
0.37 %
0.17 %
0.37 %
0.37 %
0.37 %
0.37 %
0.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.76 %
65.77 %
65.51 %
65.70 %
65.74 %
65.72 %
65.57 %
65.38 %
65.40 %
65.56 %
65.55 %
65.51 %
65.61 %
65.63 %
65.60 %
65.50 %
65.29 %
Others
6.07 %
6.17 %
6.44 %
6.25 %
6.21 %
6.22 %
6.18 %
6.37 %
6.35 %
6.39 %
6.19 %
6.44 %
6.14 %
6.12 %
6.15 %
6.25 %
6.46 %
No of Share Holders
5,949
6,082
6,129
6,213
6,225
6,226
6,226
6,274
6,289
6,268
6,275
6,254
6,262
6,254
6,382
6,576
6,510

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 124.45 147.65
27 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2025 101.90 89.50
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 72.10 67.00
23 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2024 73.50 69.41

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025May 29, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 29 2025May 29, 2025
Updates on Open OfferMay 28, 2025
Intimation With Respect To Opening Of New Corporate Office Of The CompanyMay 27, 2025
Updates on Open OfferMay 21, 2025
Updates on Open OfferMay 20, 2025
Board Meeting Intimation for Board Meeting To Be Held On Thursday May 29 2025May 14, 2025
Letter of OfferMay 13, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday May 02 2025May 02, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY APRIL 16 2025Apr 16, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 16, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2025
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015Apr 15, 2025
Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirement) Regulations 2015 Board Meeting To Be Held On Wednesday April 16 2025Apr 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2025
Closure of Trading WindowMar 31, 2025
Draft Letter of OfferFeb 28, 2025
Detailed Public StatementFeb 24, 2025
Intimation Of Signing Of Share Purchase Agreement (SPA) Between The Promoter & Promoter Group And AcquirerFeb 18, 2025
Submission Of Public Announcement To The Public Shareholders Of M/S Chemo Pharma Laboratories LimitedFeb 18, 2025
Public Announcement - Open OfferFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 28, 2025
Integrated Filing (Financial)Jan 27, 2025
Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday January 27 2025Jan 27, 2025
Board Meeting Intimation for Board Meeting To Be Held On Monday January 27 2025Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 31, 2024
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2024
Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, October 28, 2024Oct 28, 2024
Board Meeting Intimation for Board Meeting To Be Held On Monday, October 28, 2024Oct 15, 2024
Reply To The Clarification Sought On Movement In Price Of The Shares Across Exchanges Of Shares Of The CompanyOct 14, 2024
Clarification sought from Chemo Pharma Laboratories LtdOct 11, 2024
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015Oct 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 01, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 24, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2024
Reg. 34 (1) Annual Report.Aug 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2024
Intimation Of Book Closure And Record Date For The Annual General Meeting To Be Held For The Financial Year 2023-2024Jul 29, 2024
Submission Of Un-Audited Financial Results For The Quarter Ended June 30, 2024Jul 29, 2024

Technical Indicators

RSI(14)
Neutral
39.08
ATR(14)
Less Volatile
4.94
STOCH(9,6)
Oversold
3.30
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-2.41
ADX(14)
Weak Trend
19.63
UO(9)
Bullish
25.00
ROC(12)
Downtrend And Accelerating
-15.75
WillR(14)
Oversold
-100.00